Mingming Jin

3.1k total citations
72 papers, 2.2k citations indexed

About

Mingming Jin is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Mingming Jin has authored 72 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Molecular Biology, 32 papers in Cancer Research and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Mingming Jin's work include MicroRNA in disease regulation (20 papers), Cancer-related molecular mechanisms research (17 papers) and Circular RNAs in diseases (16 papers). Mingming Jin is often cited by papers focused on MicroRNA in disease regulation (20 papers), Cancer-related molecular mechanisms research (17 papers) and Circular RNAs in diseases (16 papers). Mingming Jin collaborates with scholars based in China, Hong Kong and South Korea. Mingming Jin's co-authors include Gang Huang, Qiancheng Luo, Mei Jiang, Guorong Liu, Dongfeng Guo, Guo Chen, Qian Hua, Jianjun Liu, Hang Min and Fei Xu and has published in prestigious journals such as The Science of The Total Environment, Oncogene and Frontiers in Immunology.

In The Last Decade

Mingming Jin

64 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mingming Jin China 22 1.6k 1.1k 210 184 158 72 2.2k
Lucas Treps France 16 1.2k 0.7× 686 0.6× 154 0.7× 235 1.3× 172 1.1× 28 1.9k
Xia Yang China 28 1.4k 0.9× 795 0.7× 162 0.8× 185 1.0× 110 0.7× 75 2.1k
Chao Cheng China 27 1.1k 0.7× 691 0.6× 320 1.5× 270 1.5× 124 0.8× 143 2.2k
Jie Tang China 26 1.3k 0.8× 795 0.7× 253 1.2× 212 1.2× 186 1.2× 120 2.2k
Xiaoping Zhang China 35 1.9k 1.2× 1.5k 1.4× 182 0.9× 326 1.8× 149 0.9× 79 2.9k
Hao Guo China 29 1.1k 0.7× 617 0.6× 151 0.7× 149 0.8× 152 1.0× 73 2.0k
Qishan Chen China 22 857 0.5× 551 0.5× 152 0.7× 277 1.5× 238 1.5× 38 1.7k

Countries citing papers authored by Mingming Jin

Since Specialization
Citations

This map shows the geographic impact of Mingming Jin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mingming Jin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mingming Jin more than expected).

Fields of papers citing papers by Mingming Jin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mingming Jin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mingming Jin. The network helps show where Mingming Jin may publish in the future.

Co-authorship network of co-authors of Mingming Jin

This figure shows the co-authorship network connecting the top 25 collaborators of Mingming Jin. A scholar is included among the top collaborators of Mingming Jin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mingming Jin. Mingming Jin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Jiao, et al.. (2025). Gambogenic Acid Suppresses Malignant Progression of Non-Small Cell Lung Cancer via GCH1-Mediated Ferroptosis. Pharmaceuticals. 18(3). 374–374. 2 indexed citations
2.
Jin, Mingming, et al.. (2025). Hyperoside suppresses NSCLC progression by inducing ATG13-mediated autophagy and apoptosis. Cellular Immunology. 411-412. 104947–104947.
3.
Li, Jingyi, Ziyu Chen, Mingming Jin, et al.. (2024). Histone H4K12 lactylation promotes malignancy progression in triple-negative breast cancer through SLFN5 downregulation. Cellular Signalling. 124. 111468–111468. 23 indexed citations
4.
Liu, Qingtao, Mingming Jin, Lei Wang, et al.. (2024). circFTO from M2 macrophage-derived small extracellular vesicles (sEV) enhances NSCLC malignancy by regulation miR-148a-3pPDK4 axis. Cancer Immunology Immunotherapy. 73(5). 91–91. 5 indexed citations
5.
Ji, Fang, et al.. (2024). Hsa_circ_0036872 has an important promotional effect in enhancing osteogenesis of dental pulp stem cells by regulating the miR-143-3p/IGF2 axis. International Immunopharmacology. 130. 111744–111744. 4 indexed citations
6.
Zheng, Liying, Bei Hu, Gui-fang Zhu, et al.. (2024). HPV11 targeting KDM4A regulates the polarization of macrophage M1 and promotes the development of nasal inverted papilloma. Cell Communication and Signaling. 22(1). 603–603. 2 indexed citations
7.
Jin, Mingming, et al.. (2024). KD-Club: An Efficient Exact Algorithm with New Coloring-Based Upper Bound for the Maximum k-Defective Clique Problem. Proceedings of the AAAI Conference on Artificial Intelligence. 38(18). 20735–20742.
8.
Jin, Mingming, et al.. (2024). An unsupervised deep learning network model for artifact correction of cone-beam computed tomography images. Biomedical Signal Processing and Control. 95. 106362–106362. 1 indexed citations
9.
Jin, Mingming, et al.. (2024). Can the development of the rural digital economy reduce agricultural carbon emissions? A spatiotemporal empirical study based on China's provinces. The Science of The Total Environment. 939. 173437–173437. 46 indexed citations
10.
Wang, Meng, et al.. (2024). MultiRoiMix: A Data Augmentation Method for PET/CT Multimodal Medical Images. Journal of Medical and Biological Engineering. 44(3). 366–374. 1 indexed citations
11.
Gan, Xin, Yuna Wu, Mingming Jin, et al.. (2024). Synthesis and Anti-gastric Cancer Activity by Targeting FGFR1 Pathway of Novel Asymmetric Bis-chalcone Compounds. Current Medicinal Chemistry. 31(39). 6521–6541.
12.
Li, Xue, et al.. (2023). miR-138 from ADSC Exo accelerates wound healing by targeting SIRT1/PTEN pathway to promote angiogenesis and fibrosis. Cellular Signalling. 111. 110843–110843. 4 indexed citations
13.
Liang, Shufang, Mingming Jin, Shu Li, et al.. (2023). Oleanolic acid inhibits hypoxic tumor-derived exosomes-induced premetastatic niche formation in hepatocellular carcinoma by targeting ERK1/2-NFκB signaling. Phytomedicine. 126. 155208–155208. 10 indexed citations
14.
Li, Kanghua, Xingxing Li, Huijie Zhao, et al.. (2023). Frizzled‐7‐targeting antibody (SHH002‐hu1) potently suppresses non–small‐cell lung cancer via Wnt/β‐catenin signaling. Cancer Science. 114(5). 2109–2122. 10 indexed citations
15.
Jin, Mingming, et al.. (2023). Downregulation of circ-YES1 suppresses NSCLC migration and proliferation through the miR-142-3p–HMGB1 axis. Respiratory Research. 24(1). 100–100. 6 indexed citations
16.
Liu, Qingtao, et al.. (2023). Comprehensive analysis of mitophagy-related genes in NSCLC diagnosis and immune scenery: based on bulk and single-cell RNA sequencing data. Frontiers in Immunology. 14. 1276074–1276074. 6 indexed citations
17.
Jin, Mingming, et al.. (2021). Corosolic acid reduces A549 and PC9 cell proliferation, invasion, and chemoresistance in NSCLC via inducing mitochondrial and liposomal oxidative stress. Biomedicine & Pharmacotherapy. 144. 112313–112313. 12 indexed citations
18.
Jin, Mingming, Nannan Shi, Meng Wang, et al.. (2020). CD45: a critical regulator in immune cells to predict severe and non-severe COVID-19 patients. Aging. 12(20). 19867–19879. 18 indexed citations
19.
Shao, Minghao, Mingming Jin, Shun Xu, et al.. (2020). Exosomes from Long Noncoding RNA-Gm37494-ADSCs Repair Spinal Cord Injury via Shifting Microglial M1/M2 Polarization. Inflammation. 43(4). 1536–1547. 88 indexed citations
20.
Chen, Guo, et al.. (2018). Polydatin protects against acute myocardial infarction-induced cardiac damage by activation of Nrf2/HO-1 signaling. Journal of Natural Medicines. 73(1). 85–92. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026